Clinical Trial Update: Idebenone to Treat Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for idebenone in Friedreich's ataxia is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED